Comparing clinical and economic outcomes of biologic and conventional medications in postmenopausal women with osteoporosis

Author:

Hernandez Inmaculada1,Zhang Yuting1

Affiliation:

1. Department of Health Policy and Management; Graduate School of Public Health; University of Pittsburgh; Pittsburgh PA USA

Funder

Commonwealth Foundation

Agency for Healthcare Research and Quality

Institute of Medicine

Publisher

Wiley

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference21 articles.

1. Tier 4 drugs and the fraying of the social compact;Lee;New England Journal of Medicine,2008

2. Prescription drug spending trends in the United States: looking beyond the turning point;Aitken;Health Affairs,2009

3. The market for follow-on biologics: how will it evolve?;Grabowski;Health Affairs,2006

4. Bisphosphonates: mechanism of action and role in clinical practice;Drake;Mayo Clinic Proceedings,2008

5. A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis;Body;Journal of Clinical Endocrinology and Metabolism,2002

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3